Restrictive Breathing Disorders

Restrictive breathing disorders are characterized by reduced lung expansion, leading to decreased lung volumes and impaired ventilation. Unlike obstructive disorders, airflow is typically preserved, but patients struggle with shallow, rapid breathing and a sensation of breathlessness. These disorders can be intrinsic, caused by pulmonary parenchymal diseases such as interstitial lung disease, sarcoidosis, or pulmonary fibrosis, or extrinsic, arising from conditions that limit chest wall or diaphragmatic movement, including obesity, scoliosis, or neuromuscular disorders. Clinical evaluation begins with a thorough history and physical examination, followed by pulmonary function tests that reveal decreased total lung capacity and vital capacity. Imaging techniques, particularly high-resolution CT, are instrumental in identifying structural abnormalities and assessing the extent of parenchymal involvement. Treatment strategies depend on the underlying cause: anti-inflammatory or antifibrotic therapies may slow progression in interstitial lung disease, whereas physical therapy and non-invasive ventilation support patients with neuromuscular or chest wall limitations. Pulmonary rehabilitation programs, breathing exercises, and lifestyle modifications such as weight management contribute to improving functional capacity and symptom control. Early recognition of restrictive breathing disorders is crucial, as delayed diagnosis often results in significant respiratory compromise. Emerging research into regenerative therapies, novel pharmacological agents, and mechanical support devices is expanding therapeutic possibilities. By integrating precise diagnostics, individualized treatment plans, and supportive care, the management of restrictive breathing disorders aims to preserve lung function, enhance daily activity levels, and reduce complications associated with chronic respiratory limitation.